Oncology

Showing 217–240 of 488 results

LuciBren 25 mg Tablet

LuciBren 25 mg tablets contain brensocatib, a reversible DPP1 (dipeptidyl peptidase 1) inhibitor. It is used for non-cystic fibrosis bronchiectasis

LuciBriga 180 mg Tablet

Molecule : BrigatinibManufacturer : Lucius Pharma

LuciBriga 90 mg Tablet

Molecule : BrigatinibManufacturer : Lucius Pharma

LuciBru 140 mg Tablet

Molecule : IbrutinibManufacturer : Lucius Pharma

LuciCaboz 20 mg Tablet

Molecule : CabozantinibManufacturer : Lucius Pharma

LuciCapiva 160 mg Tablet

Molecule : CapivasertibManufacturer : Lucius Pharma

LuciCapiva 200 mg Tablet

Molecule : CapivasertibManufacturer : Lucius Pharma

Lucicapma 200 mg Tablet

Molecule : CapmatinibManufacturer : Lucius Pharma

LuciCer 150 mg Capsule

Molecule : CeritinibManufacturer : Lucius Pharma

LuciCob 20 mg Tablet

Molecule : CobimetinibManufacturer : Lucius Pharma

LuciCriz 250 mg Capsule

Molecule : CrizotinibManufacturer : Lucius Pharma

Lucicyp 50 mg Tablet

Molecule : Cyproterone AcetateManufacturer : Lucius Pharma

LuciDabra 75 mg Capsule

Molecule : DabrafenibManufacturer : Lucius Pharma
LuciDabra (Dabrafenib) is a revolutionary kinase inhibitor that targets patients with unresectable or metastatic melanoma harboring the BRAF V600E mutation.

LuciDac 15 mg Tablet

Molecule : DacomitinibManufacturer : Lucius Pharma

LuciDac 45 mg Tablet

Molecule : DacomitinibManufacturer : Lucius Pharma

LuciDasa 20 mg Tablet

Molecule : DasatinibManufacturer : Lucius Pharma
LuciDasa 20 mg tablets contain dasatinib, a BCR-ABL tyrosine kinase inhibitor. It is used for Philadelphia chromosome-positive chronic myeloid leukaemia

LuciDasa 50 mg Tablet

Molecule : DasatinibManufacturer : Lucius Pharma
LuciDasa 50 mg tablets contain dasatinib, a BCR-ABL tyrosine kinase inhibitor. It is used for Philadelphia chromosome-positive chronic myeloid leukaemia

LuciDasa 70 mg Tablet

Molecule : DasatinibManufacturer : Lucius Pharma

LuciDela 150 mg Tablet

Molecule : IdelalisibManufacturer : Lucius Pharma

LuciDorda 125 mg Capsule

LuciDorda 125 mg capsules contain dordaviprone, an imipridone (ClpP agonist and DRD2 antagonist). It is used for diffuse midline glioma

LuciElace 345 mg Tablet

Molecule : ElacestrantManufacturer : Lucius Pharma

LuciElace 86 mg Tablet

Molecule : ElacestrantManufacturer : Lucius Pharma

LuciElag 150 mg Tablet

LuciElag 150 mg tablets contain elagolix, an oral GnRH receptor antagonist. It is used for the management of moderate to

LuciElag 200 mg Tablet

LuciElag 200 mg tablets contain elagolix, an oral GnRH receptor antagonist. It is used for the management of moderate to